As global markets navigate through heightened geopolitical tensions and economic uncertainties, the Swedish market remains a focal point for investors seeking growth opportunities. In this environment, companies with high insider ownership often attract attention due to their potential for aligned interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In Sweden

Click here to see the full list of 79 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Lime Technologies

Simply Wall St Growth Rating: ★★★★★☆

Overview: Lime Technologies AB (publ) offers SaaS-based CRM solutions in the Nordic region and has a market cap of SEK4.59 billion.

Operations: The company generates revenue from selling and implementing CRM software systems, totaling SEK631.84 million.

Insider Ownership: 10.7%

Earnings Growth Forecast: 22.4% p.a.

Lime Technologies shows strong growth potential, with earnings projected to increase by 22.4% annually, outpacing the Swedish market's 15.2%. Despite high debt levels, it trades at a discount of 26.4% below its fair value estimate and boasts a robust forecasted return on equity of 38.6%. Recent financials reveal steady revenue growth from SEK 290.38 million to SEK 344.14 million in six months, alongside consistent dividend payouts totaling SEK 46,492 million for 2024.

• Get an in-depth perspective on Lime Technologies' performance by reading our analyst estimates report here.
• The valuation report we've compiled suggests that Lime Technologies' current price could be quite moderate.

Medicover

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK27.72 billion.

Operations: The company generates revenue from Diagnostic Services amounting to €610 million and Healthcare Services totaling €1.32 billion.

Insider Ownership: 11.1%

Earnings Growth Forecast: 38.6% p.a.

Medicover's earnings are forecast to grow significantly at 38.6% annually, surpassing the Swedish market's average of 15.2%. Despite trading at a substantial discount of 47.1% below its estimated fair value, insider activity shows more buying than selling recently. The company anticipates organic revenue over €2.2 billion by year-end 2025, though interest payments remain inadequately covered by earnings. Recent leadership changes include Anand Patel as CFO, bringing extensive retail finance experience to Medicover's executive team.

• Click to explore a detailed breakdown of our findings in Medicover's earnings growth report.
• In light of our recent valuation report, it seems possible that Medicover is trading beyond its estimated value.

Vimian Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vimian Group AB (publ) operates in the global animal health industry, with a market capitalization of approximately SEK24.32 billion.

Operations: The company generates revenue from various segments, including Medtech (€111.91 million), Diagnostics (€20.63 million), Specialty Pharma (€158.39 million), and Veterinary Services (€53.95 million).

Insider Ownership: 11.1%

Earnings Growth Forecast: 64.1% p.a.

Vimian Group's earnings are forecast to grow significantly at 64.1% annually, outpacing the Swedish market average of 15.2%. Despite trading at a discount of 15.6% below its estimated fair value, insider activity shows more selling than buying recently, raising concerns about confidence in future performance. The company's revenue is expected to grow by 12.7% per year, faster than the Swedish market but slower than high-growth benchmarks, with recent large one-off items impacting financial results.

• Click here and access our complete growth analysis report to understand the dynamics of Vimian Group.
• Our valuation report unveils the possibility Vimian Group's shares may be trading at a discount.

Where To Now?

• Dive into all 79 of the Fast Growing Swedish Companies With High Insider Ownership we have identified here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:LIME OM:MCOV B and OM:VIMIAN.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com